AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
Total Liabilities
AstraZeneca PLC
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AstraZeneca PLC
LSE:AZN
|
Total Liabilities
$64.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Total Liabilities
£44.7B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
3%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Total Liabilities
$58.8m
|
CAGR 3-Years
45%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Indivior PLC
LSE:INDV
|
Total Liabilities
$1.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Total Liabilities
$2.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
11%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Total Liabilities
£814.2m
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
13%
|
See Also
What is AstraZeneca PLC's Total Liabilities?
Total Liabilities
64.8B
USD
Based on the financial report for Mar 31, 2024, AstraZeneca PLC's Total Liabilities amounts to 64.8B USD.
What is AstraZeneca PLC's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
6%
Over the last year, the Total Liabilities growth was 6%. The average annual Total Liabilities growth rates for AstraZeneca PLC have been 9% over the past three years , 5% over the past five years , and 6% over the past ten years .